title: OKT3 monoclonal antibody therapy and visual loss.
authors.forename: J H
authors.initials: JH
authors.lastname: Horina
authors.forename: S
authors.initials: S
authors.lastname: Horn
authors.forename: H
authors.initials: H
authors.lastname: Holzer
authors.forename: G
authors.initials: G
authors.lastname: Langmann
mesh_terms: D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000009:adverse effects; D016853:Muromonab-CD3 / Q000009:adverse effects*; D014786:Vision Disorders / Q000209:etiology*
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3